Close
Help
Need Help?



Infectious Diseases: Research and Treatment now added To Chinese Electronic Periodical Services

Posted Mon, Apr, 23,2012

Libertas is pleased to announce that Infectious Diseases: Research and Treatment is now indexed by the Chinese Electronic Periodical Services. (CEPS) and journal content will be available there soon.CEPS is operated by Airitri Inc., and in 2005 & 2007 won the ‘Best Subsidized Digital Publication award’ from the News Bureau of Executive Yuan of Taiwan.Researchers and academics can s...

Continue Reading →

Join the Clinical Medicine Insights: Urology Peer Reviewer Community

Posted Mon, Apr, 23,2012

Libertas encourages readers to register to join the Clinical Medicine Insights: Urology peer review group.  Being a volunteer peer reviewer is a great way to support Clinical Medicine Insights: Urology and assist your colleagues who have submitted manuscripts to the journal.The peer review process has been designed to make this vital task as quick and well-organized as possible so reviewers&r...

Continue Reading →

Genomics Insights Added To Socolar

Posted Mon, Apr, 23,2012

We're pleased to announce that Genomics Insights is now indexed by Socolar and journal content will be available there soon.Indexing with Socolar gives us the opportunity to reach a much wider global audience, as it is one of the most popular databases in the Chinese scientific community. Socolar indexes around 23 million articles in Chinese and English and is free for anybody to use.Indexing ...

Continue Reading →

New Cancer Informatics Call for Papers

Posted Mon, Apr, 23,2012

The Editor in Chief, Dr J. T. Efird, is pleased to announce a new call for papers for Cancer Informatics. Submissions are being accepted now.All authors who submit their manuscripts to Libertas will benefit from:Convenient 3-step online manuscript submissionNo space restrictions or color figure chargesOptional immediate publication on acceptanceInclusion of your article in: Pubmed, Chemical Abstra...

Continue Reading →

Posted in: Calls for Papers

Gene Expression to Genetical Genomics Added To Socolar

Posted Mon, Apr, 23,2012

We're pleased to announce that Gene Expression to Genetical Genomics is now indexed by Socolar and journal content will be available there soon.Indexing with Socolar gives us the opportunity to reach a much wider global audience, as it is one of the most popular databases in the Chinese scientific community. Socolar indexes around 23 million articles in Chinese and English and is free for anyb...

Continue Reading →

Get The Latest Updates By Following Ophthalmology and Eye Diseases on Twitter

Posted Mon, Apr, 23,2012

Libertas Academica has been using Twitter since February 2010 to benefit readers and authors.As a reader, by following Ophthalmology and Eye Diseases on Twitter you will be notified about new articles in your field of expertise, calls for papers, Editorial announcements, and any other important updates for the journal.We post on Twitter within minutes of a paper being published so Twitter follower...

Continue Reading →

Posted in: Social Media

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
testimonial_image
I have had a great experience with submitting my cancer prognosis study to Biomarker Insights. The comments from reviewers and associate editor are high quality and insightful. Congratulations and keep up the good work.
Dr Yi Hong Zhou (University of California, Irvine, CA, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results